FEB 10, 2021 3:45 PM PST

Black Men Respond Best to Immunotherapy for Prostate Cancer

WRITTEN BY: Annie Lennon

Researchers from Northwestern University have found that Black men and men of African ancestry respond better than men from other backgrounds to immunotherapy when being treated for prostate cancer. This comes even though they are also more likely to die of the condition.

Each year in the US, there are around 175,000 new cases of prostate cancer and around 32,000 deaths. While the severity and resulting mortality rate of the cancer are two times higher among patients of African American descent, African American men with advanced prostate cancer have improved survival outcomes after a course of immunotherapy. 

For the study, the researchers analyzed the genomics of 1,300 tumor samples, each labeled with self-identified race or genetic ancestry. In doing so, they found that men who had tumors with more immune cells known as plasma cells had an improved chance of becoming cancer-free post-surgery. While this was true regardless of men's race, they found that Black men's tumors tended to contain more of these cells than those of their white counterparts. 

"If a man's prostate cancer has numerous plasma cells, we found he had improved cancer survival," says Dr. Edward Schaeffer, lead author of the study. "Our study suggests plasma cells are important in the body's response to cancer."

"The finding comes at a time as researchers are discovering plasma cells may play a greater role in cancer immunotherapy than previously thought," says Dr. Adam Weiner, a first author of the study. "Testing for plasma cells in prostate cancer may help identify men who will benefit from immune-based treatments."

The researchers are now developing clinical trials to see whether increasing plasma cells in prostate cancers for men of all races and ancestry can both make immunotherapy more effective and improve survival outcomes.

 

Sources: News MedicalNature

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
DEC 27, 2020
Drug Discovery & Development
Attacking Mitochondria in Tumors
DEC 27, 2020
Attacking Mitochondria in Tumors
Researchers found that attacking a cell’s mitochondria can starve cancer cells. The study involves a possible ther ...
JAN 05, 2021
Drug Discovery & Development
Promising Epigenetic Treatment for Depression Works After One Dose
JAN 05, 2021
Promising Epigenetic Treatment for Depression Works After One Dose
Researchers affiliated with the University of Sao Paulo in Brazil have used epigenetic modulators to reduce stress-induc ...
FEB 12, 2021
Drug Discovery & Development
Compound Reverses ALS Neuron Damage
FEB 12, 2021
Compound Reverses ALS Neuron Damage
Scientists at Northwestern University identify the first compound that removes the ongoing degeneration of upper motor n ...
APR 06, 2021
Infographics
Psychedelic Medicine 101
APR 06, 2021
Psychedelic Medicine 101
As clinical trials for psychedelics progress, interest in psychedelics is increasing among pharmaceutical firms, clinici ...
MAR 03, 2021
Drug Discovery & Development
Keeping HIV Latent
MAR 03, 2021
Keeping HIV Latent
When (HIV) human immunodeficiency virus infects cells, it can go to sleep as opposed to make viral copies of itself&mdas ...
APR 02, 2021
Technology
Protein Modeling of SARS-CoV-2 Provides Targets for Vaccine Development
APR 02, 2021
Protein Modeling of SARS-CoV-2 Provides Targets for Vaccine Development
Recent protein modeling of the SARS-CoV-2 spike protein reveals novel areas for vaccine development. The novel SARS-CoV- ...
Loading Comments...